Lucas Capital Management »

Clearpoint Neuro shares owned by Lucas Capital Management

Quarter-by-quarter ownership of Clearpoint Neuro (CLPT) shares owned by Lucas Capital Management from 13F filings

Historical chart of Lucas Capital Management investment in Clearpoint Neuro

Tip: Access up to 7 years of quarterly data

All positions including Clearpoint Neuro held by Lucas Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Clearpoint Neuro by Lucas Capital Management

Quarter filed Position value Share count Share price at filing
2020-12-31 $266k 17k 15.90

More positions owned by Lucas Capital Management

Apple (AAPL)
Vanguard Information Technology ETF (VGT)
Invesco Qqq Trust Series 1 (QQQ)
iShares Dow Jones US Medical Dev. (IHI)
Johnson & Johnson (JNJ)
iShares NASDAQ Biotechnology Index (IBB)
Vanguard Europe Pacific ETF (VEA)
Industrial SPDR (XLI)
Financial Select Sector SPDR (XLF)
Brookfield Infrastructure Part (BIP)
Procter & Gamble Company (PG)
Vanguard Small-Cap ETF (VB)
JPMorgan Chase & Co. (JPM)
Consumer Discretionary SPDR (XLY)
Health Care SPDR (XLV)

View all positions for Lucas Capital Management

Top funds holding Clearpoint Neuro

Vanguard Group
Taylor Frigon Capital Management
Brown Advisory Holdings Incorporated
Cahill Wealth Management
CM Management
Lane Generational
Legato Capital Management
Parsons Capital Management
Citadel Advisors
Commonwealth Equity Services
Charles Schwab Investment Management
Bank of New York Mellon
UBS Group
Royce & Associates
Goldman Sachs Group

View all funds holding Clearpoint Neuro